Table 2.
Time of diagnosis CRC Stage I–III (n = 157) | UKCTOCS (n = 97) | |
---|---|---|
Peptide | Sensitivity (%)1 | Sensitivity (%)1 |
MUC4TR1 Tn | 10.8 (17/157) | 7.2 (7/97) |
MUC4TR2 Tn | 9.6 (15/157) | 6.4 (6/97) |
MUC4TR3 Tn | 17.8 (28/157) | 3.1 (3/97) |
MUC4TR4 Tn | 22.9 (36/157) | 2.0 (2/97) |
MUC4TR5 Tn | 19.7 (31/157) | 3.1 (3/97) |
recMUC4s Tn | 9.6 (15/157) | 8.2 (8/97) |
recMUC4L Tn | 12.1 (19/157) | 6.2 (6/97) |
MUC1 Tn | 19.1 (30/157) | 10.3 (10/97) |
recMUC2 Tn | 17.8 (28/157) | 5.2 (5/97) |
At 95% specificity.